These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A cold charcoal depurator for the adsorption of high quantities of urea. Giordano C; Esposito R; Bello P Kidney Int Suppl; 1976 Dec; (7):S284-8. PubMed ID: 1070548 [No Abstract] [Full Text] [Related]
7. The charcoal-coil: a dialysis-dialysate regeneration system. Malchesky PS; Surovy RM; Nosé Y Kidney Int Suppl; 1976 Dec; (7):S296-9. PubMed ID: 1070550 [No Abstract] [Full Text] [Related]
8. Fixed-bed charcoal hemoperfusion for the treatment of drug overdose. Barbour BH; LaSette AM; Koffler A Kidney Int Suppl; 1976 Dec; (7):S333-7. PubMed ID: 1070557 [No Abstract] [Full Text] [Related]
9. [Hypertension in patients undergoing periodic hemodialysis treatment]. Rizzo M; Biagioni Sodi A; Sodi A Cardiol Prat; 1972; 23(3):243-52. PubMed ID: 4654840 [No Abstract] [Full Text] [Related]
10. [Treatment of chronic kidney failure in polycystic kidney]. Pilotovich VS; Kozlov GT; Plisan SO; Shilaĭ LM; Tukaĭ NI Klin Med (Mosk); 1984 Jun; 62(6):56-60. PubMed ID: 6381879 [No Abstract] [Full Text] [Related]
11. [Adsorbents in extrarenal purification of the body]. Gorbovitskiĭ EB; Levitskiĭ ER Vestn Akad Med Nauk SSSR; 1978; (1):79-87. PubMed ID: 343427 [No Abstract] [Full Text] [Related]
12. Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis. Graham AN; Neale TJ; Hatfield PJ; Morrison RB; Meech PR; Jacobson A; Faircloth C N Z Med J; 1986 Jul; 99(805):491-3. PubMed ID: 3461382 [TBL] [Abstract][Full Text] [Related]
13. The rationale for fixed-bed charcoal in hemoperfusion. Hill JB; Palaia FL; McAdams JL; Palmer PJ; Skinner JT; Maret SM Kidney Int Suppl; 1976 Dec; (7):S328-32. PubMed ID: 1070556 [No Abstract] [Full Text] [Related]
14. [Hemodialysis during exacerbation of chronic renal insufficiency in a patient with polycystosis of the kidneys]. Burdina NA; Gerchikova TN Klin Med (Mosk); 1969 Mar; 47(3):118-9. PubMed ID: 5406804 [No Abstract] [Full Text] [Related]
15. Expectations for sorbents in uremia. Merrill JP Kidney Int Suppl; 1976 Dec; (7):S351-2. PubMed ID: 1070562 [No Abstract] [Full Text] [Related]
16. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Mendelssohn DC; Harding ME; Cardella CJ; Cook GT; Uldall PR Clin Nephrol; 1988 Dec; 30(6):315-9. PubMed ID: 3072137 [TBL] [Abstract][Full Text] [Related]
17. [Do polycystic kidneys decrease in size in patients on the dialysis-transplantation program?]. Merta M; Srp A; Prát V; Skála I; Bártová V Cas Lek Cesk; 1988 Sep; 127(36):1136-8. PubMed ID: 3052847 [No Abstract] [Full Text] [Related]
18. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure]. Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026 [No Abstract] [Full Text] [Related]
19. [Use of carbonic adsorbents in complex treatment of hepatic insufficiency]. Shalimov AA; Zubkov VI; Shalimov SA; Kolesnikov EB; Voĭtenko GN Klin Khir (1962); 1980 Mar; (3):1-4. PubMed ID: 7374050 [No Abstract] [Full Text] [Related]
20. [Cholesterin granuloma in a hemodialysis patient with polycystic kidney disease]. Maeda N; Iwasaki A; Mori Y; Ikoma F Hinyokika Kiyo; 1993 Jun; 39(6):557-9. PubMed ID: 8337983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]